Regencell Bioscience Holdings Limited
RGC
Classement en actions
#3381
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Prix de l'action
$10.41
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$5.16B
Changement (1 jour)
3.56%
Changement (1 an)
-35.07%
Pays
HK
Échange Regencell Bioscience Holdings Limited (RGC)
Catégorie
Healthcare
Ratio P/B pour Regencell Bioscience Holdings Limited (RGC)
Ratio P/B au October 2026 TTM : 300.54
Selon les derniers rapports financiers et le cours de l'action de Regencell Bioscience Holdings Limited, le ratio cours/valeur comptable actuel (TTM) est 300.54. À la fin de 2024, le ratio P/B était de 5.08.
Historique du ratio P/B pour Regencell Bioscience Holdings Limited de 2019 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 300.54 | -82.66% |
| 2025 | 1.73K | 34,010.49% |
| 2024 | 5.08 | -79.61% |
| 2023 | 24.92 | -5.54% |
| 2022 | 26.38 | -179.45% |
| 2021 | -33.21 | -33.69% |
| 2020 | -50.08 | -30.65% |
| 2019 | -72.20 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -98.32% |
IN
|
